Cargando…
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle
Duchenne muscular dystrophy (DMD) is a debilitating X-linked disorder that is fatal. DMD patients lack the expression of the structural protein dystrophin caused by mutations within the DMD gene. The absence of functional dystrophin protein results in excessive damage from normal muscle use due to t...
Autores principales: | Welch, Ryan D., Billon, Cyrielle, Valfort, Aurore-Cecile, Burris, Thomas P., Flaveny, Colin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719458/ https://www.ncbi.nlm.nih.gov/pubmed/29215066 http://dx.doi.org/10.1038/s41598-017-17496-7 |
Ejemplares similares
-
Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice
por: Welch, Ryan D., et al.
Publicado: (2020) -
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
por: Murray, Meghan H., et al.
Publicado: (2022) -
Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation
por: Amador, Ariadna, et al.
Publicado: (2016) -
A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis
por: Sengupta, Monideepa, et al.
Publicado: (2021) -
Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome
por: Welch, Ryan D., et al.
Publicado: (2017)